Dynamic Plantar Pressures Changes After Dry Needling in Flexor Digitorum Brevis Versus Non Emission Laser

NCT ID: NCT05875415

Last Updated: 2023-06-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-05-27

Study Completion Date

2023-06-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Thirty-six subjects randomly distributed between a dry needling intervention group and a control group whose intervention is a non-emission laser. All the subjects will be measured before and after the interventions of each group. The measurements will be made on a pressure platform to record the dynamic footprint variables.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Thirty-six subjects randomly distributed between a dry needling intervention group and a control group whose intervention is a non-emission laser. All the subjects will be measured before and after the interventions of each group. The measurements will be made on a pressure platform to record the dynamic footprint variables of the first step of both feet.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Flatfoot

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bilateral dry needling in Flexor Brevis Digitorum in subjects with latent trigger point

Group Type EXPERIMENTAL

Bilateral dry needling in latent trigger points of the Flexor digitorum Brevis Muscle

Intervention Type OTHER

Bilateral dry needling in latent trigger points of the Flexor digitorum Brevis Muscle in flatfoot

Bilateral non emission Laser in latent trigger points of the Flexor digitorum Brevis Muscle

Group Type SHAM_COMPARATOR

Bilateral non emission Laser in latent trigger points of the Flexor digitorum Brevis Muscle

Intervention Type OTHER

Bilateral non emission Laser in latent trigger points of the Flexor digitorum Brevis Muscle in flatfoot

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bilateral dry needling in latent trigger points of the Flexor digitorum Brevis Muscle

Bilateral dry needling in latent trigger points of the Flexor digitorum Brevis Muscle in flatfoot

Intervention Type OTHER

Bilateral non emission Laser in latent trigger points of the Flexor digitorum Brevis Muscle

Bilateral non emission Laser in latent trigger points of the Flexor digitorum Brevis Muscle in flatfoot

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals must have latent trigger point in Flexor Brevis Digitorum muscles with no other pathologies

Exclusion Criteria

* Previous lower extremities surgery.
* History of lower extremities injury with residual symptoms (pain, "giving-away" sensations) within the last year.
* Leg-length discrepancy more than 1 cm
* Balance deficits (determined by oral questionnaire regarding falls)
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mayuben Private Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

EVA MARIA MARTÍNEZ JIMENEZ

Head of Podiatry, Principal Investigator, and Physiotherapist.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eva María MartínezJiménez

Role: PRINCIPAL_INVESTIGATOR

Mayuben Clinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Eva María Martínez-Jimenez

Madrid, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1912202200923-B

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.